All Stories

  1. What Are Consumers Looking for With Boric Acid?
  2. Will artificial intelligence be the answer for the gap in vulvovaginal diseases?
  3. Polymicrobial Consortia in the Pathogenesis of Biofilm Vaginosis Visualized by FISH. Historic Review Outlining the Basic Principles of the Polymicrobial Infection Theory
  4. Evaluation of Host Gene Methylation as a Triage Test for HPV–Positive Women—A Cohort Study
  5. The genital tract microbiome: bridging the gap between hype and clinical reality
  6. Genital tract microbiota composition profiles and use of prebiotics and probiotics in gynaecological cancer prevention: review of the current evidence, the European Society of Gynaecological Oncology prevention committee statement
  7. Chlamydial and Gonococcal Genital Infections: A Narrative Review
  8. Low genitourinary tract risks in women living with the human immunodeficiency virus
  9. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) Consensus St...
  10. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus st...
  11. Vulvar High-Grade Squamous Intraepithelial Lesion and the Risk of Recurrence and Progression to Cancer
  12. Scoping review of cytolytic vaginosis literature
  13. International Society for the Study of Vulvovaginal Disease Recommendations for the Diagnosis and Treatment of Vaginitis
  14. Chronic Hypertrophic Herpes Simplex Infection: A 13-Year Delay
  15. Therapeutic Options for Chlamydia trachomatis Infection: Present and Future
  16. Reply to De Giorgi et al. Comment on “Kesić et al. Early Diagnostics of Vulvar Intraepithelial Neoplasia. Cancers 2022, 14, 1822”
  17. Efficacy of Hormonal and Nonhormonal Approaches to Vaginal Atrophy and Sexual Dysfunctions in Postmenopausal Women: A Systematic Review
  18. Vulvar Paget's disease: outcomes of 51 patients treated with imiquimod cream
  19. Vaginal Leptothrix: An Innocent Bystander?
  20. Changes in the Vaginal Microbiota of Women With Secondary Localized Provoked Vulvodynia
  21. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus sta...
  22. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Sta...
  23. Early Diagnostics of Vulvar Intraepithelial Neoplasia
  24. Wet Mount Microscopy of the Vaginal Milieu Does Not Predict the Outcome of Fertility Treatments
  25. COVID-19 related acute genital ulcer: a case report
  26. The Vaginal Microbiome: I. Research Development, Lexicon, Defining “Normal” and the Dynamics Throughout Women's Lives
  27. The Vaginal Microbiome: II. Vaginal Dysbiotic Conditions
  28. The Vaginal Microbiome: III. The Vaginal Microbiome in Various Urogenital Disorders
  29. The Vaginal Microbiome: IV. The Role of Vaginal Microbiome in Reproduction and in Gynecologic Cancers
  30. The Vaginal Microbiome: V. Therapeutic Modalities of Vaginal Microbiome Engineering and Research Challenges
  31. Vulvar High-Grade Squamous Intraepithelial Lesions and Cancer as a Risk Factor for Anal Cancer: A Review
  32. Use of Moisturizers and Lubricants for Vulvovaginal Atrophy
  33. Hormonal Approach for Postmenopausal Vulvovaginal Atrophy
  34. Genitourinary Syndrome of Menopause: Epidemiology, Physiopathology, Clinical Manifestation and Diagnostic
  35. G-spot: Fact or Fiction?: A Systematic Review
  36. Superficially Invasive Vulvar Squamous Cell Carcinoma: A 37-Year-Long Experience of a Tertiary Referral Center
  37. Diagnosis of bacterial vaginosis: Clinical or microscopic? A cross‐sectional study
  38. Cytology Is Not Reliable to Evaluate Cervical Disease Regression
  39. Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease
  40. Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy
  41. For Anal Cancer, Not All Women Are Equal
  42. Clinical validation of a new molecular test (Seegene Allplex™ Vaginitis) for the diagnosis of vaginitis: a cross‐sectional study
  43. Clarification about vulvar cancer precursor lesions
  44. The International Society for the Study of Vulvovaginal Disease Vaginal Wet Mount Microscopy Guidelines: How to Perform, Applications, and Interpretation
  45. Knowledge of Vulvar Anatomy and Self-examination in a Sample of Italian Women
  46. Letter to the editor: “Do variations in labial anatomy have an effect on recurrent urinary tract infection?”
  47. Erosive Vulvar Lichen Planus and Risk of Vulvar Neoplasia
  48. Prognostic factors for recurrence and survival in uncommon variants of vulvar cancer
  49. Cross-Protective IgG and IgA Antibodies against Oncogenic and Non-Oncogenic HPV Genotypes
  50. Impact of a High Coverage Vaccination Rate on Human Papillomavirus Infection Prevalence in Young Women: A Cross-sectional Study
  51. Better studies needed on LASER use in urinary incontinence
  52. Prognostic factors in patients with vulvar cancer: the VULCAN study
  53. Editorial Comment: The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document
  54. Better triage tests needed for HPV‐positive women
  55. Adult Vulvar Lichen Sclerosus: Can Experts Agree on the Assessment of Disease Severity?
  56. Corrigendum
  57. The International Classification of Diseases, 11th Revision: A Step-Back for Women With Vulvodynia?
  58. Diagnosis of vaginitis: time to improve and move on
  59. Response letter to comments related to “The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document”
  60. Systematic review and meta-analysis of the effects of treatment modalities for vestibulodynia in women
  61. Vulvodynia: a neglected chronic pain diagnosis
  62. Academic cosmetic gynaecology and energy-based therapies: ambiguities, explorations, and FDA advisories
  63. Descriptors of Vulvodynia: A Multisocietal Definition Consensus (International Society for the Study of Vulvovaginal Disease, the International Society for the Study of Women Sexual Health, and the International Pelvic Pain Society)
  64. Impact of the Sampling Site in the Result of Wet Mount Microscopy
  65. The Clinical Role of LASER for Vulvar and Vaginal Treatments in Gynecology and Female Urology: An ICS/ISSVD Best Practice Consensus Document
  66. The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document
  67. The energy based devices for vaginal “rejuvenation,” urinary incontinence, vaginal cosmetic procedures, and other vulvo‐vaginal disorders: An international multidisciplinary expert panel opinion
  68. Immediate Loop Electrode Excisional Procedure for High-Grade Cervical Cytology: One Size Fits All?
  69. Vulvodynia: A disease commonly hidden in plain sight
  70. International Society for the Study of Vulvovaginal Disease Recommendations Regarding Female Cosmetic Genital Surgery
  71. To the Editor:
  72. Bioengineering Organs for Blood Detoxification
  73. The ReCiDiF method to treat recurrent vulvovaginal candidosis: A friend with benefits
  74. Diagnosis and management of vulvodynia in postmenopausal women
  75. Aerobic vaginitis: no longer a stranger
  76. Clinical Validation of a Test for the Diagnosis of Vaginitis: Correction
  77. Clinical Validation of a Test for the Diagnosis of Vaginitis
  78. Lichen sclerosus in women: a review
  79. Survey on Aesthetic Vulvovaginal Procedures: What do Portuguese Doctors and Medical Students Think?
  80. Women without vulvodynia can have a positive ‘Q-tip test’: a cross sectional study
  81. P-04-003 Prevalence of Sexually Transmitted Diseases Among Women in Principe Island
  82. Deconstructing the genitourinary syndrome of menopause
  83. Genital Tract Infections in an Isolated Community: 100 Women of the Príncipe Island
  84. Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504)
  85. Is the DSM-V Leading to the Nondiagnosis of Vulvodynia?
  86. Lipschütz ulcers: should we rethink this? An analysis of 33 cases
  87. Bacterial vaginosis and inflammatory response showed association with severity of cervical neoplasia in HPV-positive women
  88. Bacterial vaginosis, aerobic vaginitis, vaginal inflammation and major Pap smear abnormalities
  89. The “Genitourinary Syndrome of Menopause”
  90. Emphysematous Vaginitis
  91. What Differentiates Symptomatic from Asymptomatic Women with Lichen Sclerosus?
  92. Prevalence of vulvodynia and risk factors for the condition in Portugal
  93. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism
  94. Mycoplasma pneumoniae
  95. Lichen Sclerosus in Breast Cancer Survivor
  96. Ovarian intratumoral 21-hydroxylase deficiency in a postmenopausal hirsute woman
  97. Sclerosing stromal tumour of the ovary associated with Meigs' syndrome and elevated CA125
  98. Case report: intra-partum utero-ovarian vessels rupture
  99. Use of extensible internal device in the femur of young dogs
  100. L-band land mobile satellite (LMS) amplitude and multipath phase modeling in urban areas
  101. Mobile and Base Station Diversity Simulation Experiments in a Mobile Communications Course